Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

L-ARGININE HYDROCHLORIDE INJECTION 250 MG

ARGININE HYDROCHLORIDE : 250 MG · DIN 00399736 · SANDOZ CANADA INCORPORATED

Health Canada status: MARKETED

L-ARGININE HYDROCHLORIDE INJECTION 250 MG LIQUID - DIN 00399736
L-ARGININE HYDROCHLORIDE INJECTION — DIN 00399736. Product photograph held by Nexara Health.

What is L-ARGININE HYDROCHLORIDE INJECTION?

L-ARGININE HYDROCHLORIDE INJECTION 250 MG contains ARGININE HYDROCHLORIDE : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 00399736, held by SANDOZ CANADA INCORPORATED, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 15-Jun-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00399736
Brand nameL-ARGININE HYDROCHLORIDE INJECTION
Generic / active ingredientARGININE HYDROCHLORIDE : 250 MG
ManufacturerSANDOZ CANADA INCORPORATED
Strength250 MG
Dosage formLIQUID
Route of administrationINTRAVENOUS
ScheduleEthical
ATC codeV04CD TESTS FOR PITUITARY FUNCTION
AHFS class56:22.08
BiosimilarNo
Health Canada statusMARKETED
Status date15-Jun-2006
Original market date1979-12-31 00:00:00

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for L-ARGININE HYDROCHLORIDE INJECTION

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for L-ARGININE HYDROCHLORIDE INJECTION

Health Canada Drug Product Database (DPD), DIN 00399736. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.